{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:50:39Z","timestamp":1789098639269,"version":"build-2803163510"},"reference-count":227,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes\nthe death of motor neurons and consequent muscle paralysis. Despite many efforts to address it, current\ntherapy targeting ALS remains limited, increasing the interest in complementary therapies. Over\nthe years, several herbal preparations and medicinal plants have been studied to prevent and treat this\ndisease, which has received remarkable attention due to their blood-brain barrier penetration properties\nand low toxicity. Thus, this review presents the therapeutic potential of a variety of medicinal herbs\nand their relationship with ALS and their physiopathological pathways.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x22666231016153606","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T19:01:39Z","timestamp":1697742099000},"page":"1169-1188","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insights on Natural Products Against Amyotrophic Lateral Sclerosis\n(ALS)"],"prefix":"10.2174","volume":"22","author":[{"given":"Kadja Luana Chagas","family":"Monteiro","sequence":"first","affiliation":[{"name":"Research Group on Therapeutic Strategies - GPET, Laboratory of Synthesis and Research in Medicinal Chemistry -\nLSPMED, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970, Macei\u00f3, Alagoas,\nBrazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcone Gomes","family":"dos Santos Alc\u00e2ntara","sequence":"additional","affiliation":[{"name":"Research Group on Therapeutic Strategies - GPET, Laboratory of Synthesis and Research in Medicinal Chemistry -\nLSPMED, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970, Macei\u00f3, Alagoas,\nBrazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Mendon\u00e7a","family":"de Aquino","sequence":"additional","affiliation":[{"name":"Research Group on Therapeutic Strategies - GPET, Laboratory of Synthesis and Research in Medicinal Chemistry -\nLSPMED, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970, Macei\u00f3, Alagoas,\nBrazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeildo Ferreira","family":"da Silva-J\u00fanior","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970, Macei\u00f3, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"Taylor J.P.","year":"2016","unstructured":"Taylor J.P.; Brown R.H.; Cleveland D.W.; Decoding ALS: From genes to mechanism. Nature  2016,539(7628),197-206","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"6","author":"Zarei S.","year":"2015","unstructured":"Zarei S.; Carr K.; Reiley L.; Diaz K.; Guerra O.; Altamirano P.; Pagani W.; Lodin D.; Orozco G.; Chinea A.; A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int  2015,6(1),171","journal-title":"Surg Neurol Int"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1468-1331.2008.02307.x","volume":"15","author":"Gil J.","year":"2008","unstructured":"Gil J.; Funalot B.; Verschueren A.; Danel-Brunaud V.; Camu W.; Vandenberghe N.; Desnuelle C.; Guy N.; Camdessanche J.P.; Cintas P.; Carluer L.; Pittion S.; Nicolas G.; Corcia P.; Fleury M.C.; Maugras C.; Besson G.; Le Masson G.; Couratier P.; Causes of death amongst French patients with amyotrophic lateral sclerosis: A prospective study. Eur J Neurol  2008,15(11),1245-1251","journal-title":"Eur J Neurol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1600-0404.2009.01290.x","volume":"122","author":"Spataro R.","year":"2010","unstructured":"Spataro R.; Lo Re M.; Piccoli T.; Piccoli F.; La Bella V.; Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand  2010,122(3),217-223","journal-title":"Acta Neurol Scand"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","volume":"12","author":"Turner M.R.","year":"2013","unstructured":"Turner M.R.; Hardiman O.; Benatar M.; Brooks B.R.; Chio A.; de Carvalho M.; Ince P.G.; Lin C.; Miller R.G.; Mitsumoto H.; Nicholson G.; Ravits J.; Shaw P.J.; Swash M.; Talbot K.; Traynor B.J.; Van den Berg L.H.; Veldink J.H.; Vucic S.; Kiernan M.C.; Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol  2013,12(3),310-322","journal-title":"Lancet Neurol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"Mejzini R.","year":"2019","unstructured":"Mejzini R.; Flynn L.L.; Pitout I.L.; Fletcher S.; Wilton S.D.; Akkari P.A.; ALS genetics, mechanisms, and therapeutics: Where are we now? Front Neurosci  2019,13,1310","journal-title":"Front Neurosci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1389202917666160803162309","volume":"18","author":"Torquato H.","year":"2017","unstructured":"Torquato H.; Goettert M.; Justo G.; Paredes-Gamero E.; Anti-cancer phytometabolites targeting cancer stem cells. Curr Genomics  2017,18(2),156-174","journal-title":"Curr Genomics"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1471-4159.2009.06562.x","volume":"112","author":"Kim J.","year":"2010","unstructured":"Kim J.; Lee H.J.; Lee K.W.; Naturally occurring phytochemicals for the prevention of Alzheimer\u2019s disease. J Neurochem  2010,112(6),1415-1430","journal-title":"J Neurochem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4236\/pp.2013.43A003","volume":"04","author":"Lahlou M.","year":"2013","unstructured":"Lahlou M.; The success of natural products in drug discovery. Pharmacol and Pharm  2013,04,17-31","journal-title":"Pharmacol and Pharm"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/(SICI)1521-3773(19990301)38:5<643:AID-ANIE643>3.0.CO;2-G","volume":"38","author":"Henkel T.","year":"1999","unstructured":"Henkel T.; Brunne R.M.; M&#xFC;ller H.; Reichel F.; Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed  1999,38(5),643-647","journal-title":"Angew Chem Int Ed"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1021\/cc000097l","volume":"3","author":"Lee M.L.","year":"2001","unstructured":"Lee M.L.; Schneider G.; Scaffold architecture and pharmacophoric properties of natural products and trade drugs: Application in the design of natural product-based combinatorial libraries. J Comb Chem  2001,3(3),284-289","journal-title":"J Comb Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"104253","DOI":"10.1016\/j.phrs.2019.104253","volume":"145","author":"Jin X.","year":"2019","unstructured":"Jin X.; Liu M.Y.; Zhang D.F.; Zhong X.; Du K.; Qian P.; Gao H.; Wei M.J.; Natural products as a potential modulator of microglial polarization in neurodegenerative diseases. Pharmacol Res  2019,145,104253","journal-title":"Pharmacol Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fnagi.2017.00233","volume":"9","author":"Liu Z.","year":"2017","unstructured":"Liu Z.; Ran Y.; Huang S.; Wen S.; Zhang W.; Liu X.; Ji Z.; Geng X.; Ji X.; Du H.; Leak R.K.; Hu X.; Curcumin protects against ischemic stroke by titrating microglia\/macrophage polarization. Front Aging Neurosci  2017,9,233","journal-title":"Front Aging Neurosci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijms20205170","volume":"20","author":"Di Paolo M.","year":"2019","unstructured":"Di Paolo M.; Papi L.; Gori F.; Turillazzi E.; Natural products in neurodegenerative diseases: A great promise but an ethical challenge. Int J Mol Sci  2019,20(20),5170","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5642029","volume":"2020","author":"Silva J.M.","year":"2020","unstructured":"Silva J.M.; Nobre M.S.C.; Albino S.L.; L&#xF3;cio L.L.; Nascimento A.P.S.; Scotti L.; Scotti M.T.; Oshiro-Junior J.A.; Lima M.C.A.; Mendon&#xE7;a-Junior F.J.B.; Moura R.O.; Secondary metabolites with antioxidant activities for the putative treatment of amyotrophic lateral sclerosis (ALS): &#x201C;Experimental evidences. Oxid Med Cell Longev  2020,2020,1-22","journal-title":"Oxid Med Cell Longev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"103630","DOI":"10.1016\/j.jff.2019.103630","volume":"64","author":"Shao J.W.","year":"2020","unstructured":"Shao J.W.; Jiang J.L.; Zou J.J.; Yang M.Y.; Chen F.M.; Zhang Y.J.; Jia L.; Therapeutic potential of ginsenosides on diabetes: From hypoglycemic mechanism to clinical trials. J Funct Foods  2020,64,103630","journal-title":"J Funct Foods"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"Pizzino G.","year":"2017","unstructured":"Pizzino G.; Irrera N.; Cucinotta M.; Pallio G.; Mannino F.; Arcoraci V.; Squadrito F.; Altavilla D.; Bitto A.; Oxidative stress: Harms and benefits for human health. Oxid Med Cell Longev  2017,2017,1-13","journal-title":"Oxid Med Cell Longev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2105607","volume":"2019","author":"Cenini G.","year":"2019","unstructured":"Cenini G.; Lloret A.; Cascella R.; Oxidative stress in neurodegenerative diseases: From a mitochondrial point of view. Oxid Med Cell Longev  2019,2019,1-18","journal-title":"Oxid Med Cell Longev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuropharm.2008.02.017","volume":"55","author":"Dirnagl U.","year":"2008","unstructured":"Dirnagl U.; Meisel A.; Endogenous neuroprotection: Mitochondria as gateways to cerebral preconditioning? Neuropharmacology  2008,55(3),334-344","journal-title":"Neuropharmacology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1474-4422(09)70054-7","volume":"8","author":"Dirnagl U.","year":"2009","unstructured":"Dirnagl U.; Becker K.; Meisel A.; Preconditioning and tolerance against cerebral ischaemia: From experimental strategies to clinical use. Lancet Neurol  2009,8(4),398-412","journal-title":"Lancet Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1089\/ars.2009.3074","volume":"13","author":"Calabrese V.","year":"2010","unstructured":"Calabrese V.; Cornelius C.; Dinkova-Kostova A.T.; Calabrese E.J.; Mattson M.P.; Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal  2010,13(11),1763-1811","journal-title":"Antioxid Redox Signal"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/biof.22","volume":"35","author":"Calabrese V.","year":"2009","unstructured":"Calabrese V.; Cornelius C.; Dinkova-Kostova A.T.; Calabrese E.J.; Vitagenes, cellular stress response, and acetylcarnitine: Relevance to hormesis. Biofactors  2009,35(2),146-160","journal-title":"Biofactors"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10522-012-9374-7","volume":"13","author":"Calabrese E.J.","year":"2012","unstructured":"Calabrese E.J.; Iavicoli I.; Calabrese V.; Hormesis: Why it is important to biogerontologists. Biogerontology  2012,13(3),215-235","journal-title":"Biogerontology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","volume":"23","author":"Sies H.","year":"2022","unstructured":"Sies H.; Belousov V.V.; Chandel N.S.; Davies M.J.; Jones D.P.; Mann G.E.; Murphy M.P.; Yamamoto M.; Winterbourn C.; Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol  2022,23(7),499-515","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"Sies H.","year":"2020","unstructured":"Sies H.; Jones D.P.; Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol  2020,21(7),363-383","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.dnarep.2005.03.002","volume":"5","author":"Van Houten B.","year":"2006","unstructured":"Van Houten B.; Woshner V.; Santos J.H.; Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair  2006,5(2),145-152","journal-title":"DNA Repair"},{"key":"ref=27","first-page":"30","volume":"2","author":"Selvaraji S.","year":"2019","unstructured":"Selvaraji S.; Poh L.; Natarajan V.; Mallilankaraman K.; Arumugam T.V.; Negative conditioning of mitochondrial dysfunction in age-related neurodegenerative diseases. Cond Med  2019,2(1),30-39","journal-title":"Cond Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/cns.13116","volume":"25","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Xu E.; Musich P.R.; Lin F.; Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther  2019,25(7),816-824","journal-title":"CNS Neurosci Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/biom11030437","volume":"11","author":"Hemerkov&#xE1; P.","year":"2021","unstructured":"Hemerkov&#xE1; P.; Vali\u0161 M.; Role of oxidative stress in the pathogenesis of amyotrophic lateral sclerosis: Antioxidant metalloenzymes and therapeutic strategies. Biomolecules  2021,11(3),437","journal-title":"Biomolecules"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.pharep.2014.02.021","volume":"66","author":"Golenia A.","year":"2014","unstructured":"Golenia A.; Le&#x15B;kiewicz M.; Regulska M.; Budziszewska B.; Szcz\u0119sny E.; Jagie\u0142a J.; Wnuk M.; Ostrowska M.; Laso\u0144 W.; Basta-Kaim A.; S\u0142owik A.; Catalase activity in blood fractions of patients with sporadic ALS. Pharmacol Rep  2014,66(4),704-707","journal-title":"Pharmacol Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/jnnp.2005.072710","volume":"77","author":"Tabrizi S.","year":"2006","unstructured":"Tabrizi S.; Neurodegenerative diseases neurobiology pathogenesis and therapeutics. J Neurol Neurosurg Psychiatry  2006,77(2),284-284","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1873-3468.12964","volume":"592","author":"Angelova P.R.","year":"2018","unstructured":"Angelova P.R.; Abramov A.Y.; Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett  2018,592(5),692-702","journal-title":"FEBS Lett"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e103438","DOI":"10.1371\/journal.pone.0103438","volume":"9","author":"Pehar M.","year":"2014","unstructured":"Pehar M.; Beeson G.; Beeson C.C.; Johnson J.A.; Vargas M.R.; Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G\u2079&#xB3;A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice. PLoS One  2014,9(7),e103438","journal-title":"PLoS One"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e68256","DOI":"10.1371\/journal.pone.0068256","volume":"8","author":"Richardson K.","year":"2013","unstructured":"Richardson K.; Allen S.P.; Mortiboys H.; Grierson A.J.; Wharton S.B.; Ince P.G.; Shaw P.J.; Heath P.R.; The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type. PLoS One  2013,8(6),e68256","journal-title":"PLoS One"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.nbd.2008.08.010","volume":"32","author":"Ahtoniemi T.","year":"2008","unstructured":"Ahtoniemi T.; Jaronen M.; Keksa-Goldsteine V.; Goldsteins G.; Koistinaho J.; Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane. Neurobiol Dis  2008,32(3),479-485","journal-title":"Neurobiol Dis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.phrs.2018.09.008","volume":"138","author":"Xiao Y.","year":"2018","unstructured":"Xiao Y.; Karam C.; Yi J.; Zhang L.; Li X.; Yoon D.; Wang H.; Dhakal K.; Ramlow P.; Yu T.; Mo Z.; Ma J.; Zhou J.; ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression. Pharmacol Res  2018,138,25-36","journal-title":"Pharmacol Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","volume":"27","author":"Bruijn L.I.","year":"2004","unstructured":"Bruijn L.I.; Miller T.M.; Cleveland D.W.; Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci  2004,27(1),723-749","journal-title":"Annu Rev Neurosci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1523\/JNEUROSCI.4385-04.2005","volume":"25","author":"Vijayvergiya C.","year":"2005","unstructured":"Vijayvergiya C.; Beal M.F.; Buck J.; Manfredi G.; Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci  2005,25(10),2463-2470","journal-title":"J Neurosci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuint.2008.01.009","volume":"52","author":"Babu G.N.","year":"2008","unstructured":"Babu G.N.; Kumar A.; Chandra R.; Puri S.K.; Singh R.L.; Kalita J.; Misra U.K.; Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem Int  2008,52(6),1284-1289","journal-title":"Neurochem Int"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1212\/WNL.0000000000001588","volume":"84","author":"Ikawa M.","year":"2015","unstructured":"Ikawa M.; Okazawa H.; Tsujikawa T.; Matsunaga A.; Yamamura O.; Mori T.; Hamano T.; Kiyono Y.; Nakamoto Y.; Yoneda M.; Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study. Neurology  2015,84(20),2033-2039","journal-title":"Neurology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12974-015-0350-4","volume":"12","author":"Ehrhart J.","year":"2015","unstructured":"Ehrhart J.; Smith A.J.; Kuzmin-Nichols N.; Zesiewicz T.A.; Jahan I.; Shytle R.D.; Kim S.H.; Sanberg C.D.; Vu T.H.; Gooch C.L.; Sanberg P.R.; Garbuzova-Davis S.; Humoral factors in ALS patients during disease progression. J Neuroinflammation  2015,12(1),127","journal-title":"J Neuroinflammation"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fncel.2014.00131","volume":"8","author":"Pollari E.","year":"2014","unstructured":"Pollari E.; Goldsteins G.; Bart G.; Koistinaho J.; Giniatullin R.; The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci  2014,8,131","journal-title":"Front Cell Neurosci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.bbadis.2014.02.009","volume":"1842","author":"Tan W.","year":"2014","unstructured":"Tan W.; Pasinelli P.; Trotti D.; Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim Biophys Acta Mol Basis Dis  2014,1842(8),1295-1301","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/432626","volume":"2014","author":"LoGerfo A.","year":"2014","unstructured":"LoGerfo A.; Chico L.; Borgia L.; Petrozzi L.; Rocchi A.; D\u2019Amelio A.; Carlesi C.; Ienco E.; Mancuso M.; Siciliano G.; Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients. Oxid Med Cell Longev  2014,2014,1-9","journal-title":"Oxid Med Cell Longev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrn2214","volume":"8","author":"Calabrese V.","year":"2007","unstructured":"Calabrese V.; Mancuso C.; Calvani M.; Rizzarelli E.; Butterfield D.A.; Giuffrida Stella A.M.; Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity. Nat Rev Neurosci  2007,8(10),766-775","journal-title":"Nat Rev Neurosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1179\/135100006X154978","volume":"11","author":"Mancuso C.","year":"2006","unstructured":"Mancuso C.; Pani G.; Calabrese V.; Bilirubin: An endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep  2006,11(5),207-213","journal-title":"Redox Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/jnr.10810","volume":"74","author":"Drake J.","year":"2003","unstructured":"Drake J.; Sultana R.; Aksenova M.; Calabrese V.; Butterfield D.A.; Elevation of mitochondrial glutathione by? -glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J Neurosci Res  2003,74(6),917-927","journal-title":"J Neurosci Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/antiox9090824","volume":"9","author":"Siracusa R.","year":"2020","unstructured":"Siracusa R.; Scuto M.; Fusco R.; Trovato A.; Ontario M.L.; Crea R.; Di Paola R.; Cuzzocrea S.; Calabrese V.; Anti-inflammatory and anti-oxidant activity of hidrox&#xAE; in rotenone-induced parkinson\u2019s disease in mice. Antioxidants  2020,9(9),824","journal-title":"Antioxidants"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8748253","volume":"2019","author":"Forni C.","year":"2019","unstructured":"Forni C.; Facchiano F.; Bartoli M.; Pieretti S.; Facchiano A.; D\u2019Arcangelo D.; Norelli S.; Valle G.; Nisini R.; Beninati S.; Tabolacci C.; Jadeja R.N.; Beneficial role of phytochemicals on oxidative stress and age-related diseases. BioMed Res Int  2019,2019,1-16","journal-title":"BioMed Res Int"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2174\/1871527317666180720162029","volume":"17","author":"Chico L.","year":"2018","unstructured":"Chico L.; Ienco E.C.; Bisordi C.; Lo Gerfo A.; Petrozzi L.; Petrucci A.; Mancuso M.; Siciliano G.; Amyotrophic lateral sclerosis and oxidative stress: A double-blind therapeutic trial after curcumin supplementation. CNS Neurol Disord Drug Targets  2018,17(10),767-779","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/157488912803252032","volume":"7","author":"Kim D.S.","year":"2012","unstructured":"Kim D.S.; Kim J.Y.; Han Y.; Curcuminoids in neurodegenerative diseases. Recent Patents CNS Drug Discov  2012,7(3),184-204","journal-title":"Recent Patents CNS Drug Discov"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1517\/13543784.2012.693479","volume":"21","author":"Darvesh A.S.","year":"2012","unstructured":"Darvesh A.S.; Carroll R.T.; Bishayee A.; Novotny N.A.; Geldenhuys W.J.; Van der Schyf C.J.; Curcumin and neurodegenerative diseases: A perspective. Expert Opin Investig Drugs  2012,21(8),1123-1140","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1248\/bpb.34.1194","volume":"34","author":"Jiang H.","year":"2011","unstructured":"Jiang H.; Tian X.; Guo Y.; Duan W.; Bu H.; Li C.; Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity. Biol Pharm Bull  2011,34(8),1194-1197","journal-title":"Biol Pharm Bull"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuroscience.2014.04.032","volume":"272","author":"Dong H.","year":"2014","unstructured":"Dong H.; Xu L.; Wu L.; Wang X.; Duan W.; Li H.; Li C.; Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS. Neuroscience  2014,272,141-153","journal-title":"Neuroscience"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1042\/BST0390954","volume":"39","author":"Janssens J.","year":"2011","unstructured":"Janssens J.; Kleinberger G.; Wils H.; Van Broeckhoven C.; The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Biochem Soc Trans  2011,39(4),954-959","journal-title":"Biochem Soc Trans"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","volume":"21","author":"Mackenzie I.R.A.","year":"2008","unstructured":"Mackenzie I.R.A.; Rademakers R.; The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol  2008,21(6),693-700","journal-title":"Curr Opin Neurol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainresbull.2012.09.005","volume":"89","author":"Lu J.","year":"2012","unstructured":"Lu J.; Duan W.; Guo Y.; Jiang H.; Li Z.; Huang J.; Hong K.; Li C.; Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin. Brain Res Bull  2012,89(5-6),185-190","journal-title":"Brain Res Bull"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bbapap.2015.01.014","volume":"1854","author":"Bhatia N.K.","year":"2015","unstructured":"Bhatia N.K.; Srivastava A.; Katyal N.; Jain N.; Khan M.A.I.; Kundu B.; Deep S.; Curcumin binds to the pre-fibrillar aggregates of Cu\/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim Biophys Acta Proteins Proteomics  2015,1854(5),426-436","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/gerona\/gls070","volume":"68","author":"Strong R.","year":"2013","unstructured":"Strong R.; Miller R.A.; Astle C.M.; Baur J.A.; de Cabo R.; Fernandez E.; Guo W.; Javors M.; Kirkland J.L.; Nelson J.F.; Sinclair D.A.; Teter B.; Williams D.; Zaveri N.; Nadon N.L.; Harrison D.E.; Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci  2013,68(1),6-16","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"Anand P.","year":"2007","unstructured":"Anand P.; Kunnumakkara A.B.; Newman R.A.; Aggarwal B.B.; Bioavailability of curcumin: Problems and promises. Mol Pharm  2007,4(6),807-818","journal-title":"Mol Pharm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","volume":"24","author":"Liu W.","year":"2016","unstructured":"Liu W.; Zhai Y.; Heng X.; Che F.Y.; Chen W.; Sun D.; Zhai G.; Oral bioavailability of curcumin: Problems and advancements. J Drug Target  2016,24(8),694-702","journal-title":"J Drug Target"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.colsurfb.2014.11.034","volume":"125","author":"Tripodo G.","year":"2015","unstructured":"Tripodo G.; Chlapanidas T.; Perteghella S.; Vigani B.; Mandracchia D.; Trapani A.; Galuzzi M.; Tosca M.C.; Antonioli B.; Gaetani P.; Marazzi M.; Torre M.L.; Mesenchymal stromal cells loading curcumin-INVITE-micelles: A drug delivery system for neurodegenerative diseases. Colloids Surf B Biointerfaces  2015,125,300-308","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.expneurol.2005.09.004","volume":"197","author":"Wu A.","year":"2006","unstructured":"Wu A.; Ying Z.; Gomez-Pinilla F.; Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol  2006,197(2),309-317","journal-title":"Exp Neurol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00204-017-1939-4","volume":"91","author":"Ullah F.","year":"2017","unstructured":"Ullah F.; Liang A.; Rangel A.; Gyengesi E.; Niedermayer G.; M&#xFC;nch G.; High bioavailability curcumin: An anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation. Arch Toxicol  2017,91(4),1623-1634","journal-title":"Arch Toxicol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/medicines5040126","volume":"5","author":"Rakotoarisoa M.","year":"2018","unstructured":"Rakotoarisoa M.; Angelova A.; Amphiphilic nanocarrier systems for curcumin delivery in neurodegenerative disorders. Medicines  2018,5(4),126","journal-title":"Medicines"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s13311-018-0606-7","volume":"15","author":"Ahmadi M.","year":"2018","unstructured":"Ahmadi M.; Agah E.; Nafissi S.; Jaafari M.R.; Harirchian M.H.; Sarraf P.; Faghihi-Kashani S.; Hosseini S.J.; Ghoreishi A.; Aghamollaii V.; Hosseini M.; Tafakhori A.; Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A pilot randomized clinical trial. Neurotherapeutics  2018,15(2),430-438","journal-title":"Neurotherapeutics"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12640-019-00030-0","volume":"36","author":"Ghasemi F.","year":"2019","unstructured":"Ghasemi F.; Bagheri H.; Barreto G.E.; Read M.I.; Sahebkar A.; Effects of curcumin on microglial cells. Neurotox Res  2019,36(1),12-26","journal-title":"Neurotox Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1381-5148(02)00091-3","volume":"52","author":"Handique J.G.","year":"2002","unstructured":"Handique J.G.; Baruah J.B.; Polyphenolic compounds: An overview. React Funct Polym  2002,52(3),163-188","journal-title":"React Funct Polym"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neulet.2011.08.047","volume":"503","author":"Wang J.","year":"2011","unstructured":"Wang J.; Zhang Y.; Tang L.; Zhang N.; Fan D.; Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci Lett  2011,503(3),250-255","journal-title":"Neurosci Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.freeradbiomed.2009.01.019","volume":"46","author":"Barber S.C.","year":"2009","unstructured":"Barber S.C.; Higginbottom A.; Mead R.J.; Barber S.; Shaw P.J.; An in vitro screening cascade to identify neuroprotective antioxidants in ALS. Free Radic Biol Med  2009,46(8),1127-1138","journal-title":"Free Radic Biol Med"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","volume":"11","author":"Mancuso R.","year":"2014","unstructured":"Mancuso R.; del Valle J.; Modol L.; Martinez A.; Granado-Serrano A.B.; Ramirez-N&#xFA;&#xF1;ez O.; Pall&#xE1;s M.; Portero-Otin M.; Osta R.; Navarro X.; Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics  2014,11(2),419-432","journal-title":"Neurotherapeutics"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/483501","volume":"2014","author":"Song L.","year":"2014","unstructured":"Song L.; Chen L.; Zhang X.; Li J.; Le W.; Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. BioMed Res Int  2014,2014,1-10","journal-title":"BioMed Res Int"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1750-1172-9-78","volume":"9","author":"Mancuso R.","year":"2014","unstructured":"Mancuso R.; del Valle J.; Morell M.; Pall&#xE1;s M.; Osta R.; Navarro X.; Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G93A ALS mice: Overlapping effects or limited therapeutic opportunity? Orphanet J Rare Dis  2014,9(1),78","journal-title":"Orphanet J Rare Dis"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s10822-018-0175-1","volume":"32","author":"Srinivasan E.","year":"2018","unstructured":"Srinivasan E.; Rajasekaran R.; Quantum chemical and molecular mechanics studies on the assessment of interactions between resveratrol and mutant SOD1 (G93A) protein. J Comput Aided Mol Des  2018,32(12),1347-1361","journal-title":"J Comput Aided Mol Des"},{"key":"ref=75","first-page":"110","volume":"13","author":"Yun Y.C.","year":"2018","unstructured":"Yun Y.C.; Jeong S.; Kim S.H.; Cho G.; Reduced sirtuin 1\/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol. J Tissue Eng Regen Med  2018,13(1),110-115","journal-title":"J Tissue Eng Regen Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neuro.2018.11.009","volume":"71","author":"Laudati G.","year":"2019","unstructured":"Laudati G.; Mascolo L.; Guida N.; Sirabella R.; Pizzorusso V.; Bruzzaniti S.; Serani A.; Di Renzo G.; Canzoniero L.M.T.; Formisano L.; Resveratrol treatment reduces the vulnerability of SH-SY5Y cells and cortical neurons overexpressing SOD1-G93A to Thimerosal toxicity through SIRT1\/DREAM\/PDYN pathway. Neurotoxicology  2019,71,6-15","journal-title":"Neurotoxicology"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/fsn3.1324","volume":"8","author":"Caplliure-Llopis J.","year":"2020","unstructured":"Caplliure-Llopis J.; Peralta-Chamba T.; Carrera-Juli&#xE1; S.; Cuerda-Ballester M.; Drehmer-Rieger E.; L&#xF3;pez-Rodriguez M.M.; Rubia Ort&#xED; J.E.; Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review. Food Sci Nutr  2020,8(1),23-35","journal-title":"Food Sci Nutr"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1021\/jf405820v","volume":"62","author":"Hu T.","year":"2014","unstructured":"Hu T.; He X.W.; Jiang J.G.; Xu X.L.; Hydroxytyrosol and its potential therapeutic effects. J Agric Food Chem  2014,62(7),1449-1455","journal-title":"J Agric Food Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.phrs.2019.03.005","volume":"143","author":"de Pablos R.M.","year":"2019","unstructured":"de Pablos R.M.; Espinosa-Oliva A.M.; Hornedo-Ortega R.; Cano M.; Arguelles S.; Hydroxytyrosol protects from aging process via AMPK and autophagy; a review of its effects on cancer, metabolic syndrome, osteoporosis, immune-mediated and neurodegenerative diseases. Pharmacol Res  2019,143,58-72","journal-title":"Pharmacol Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jnutbio.2014.04.005","volume":"25","author":"Oliv&#xE1;n S.","year":"2014","unstructured":"Oliv&#xE1;n S.; Mart&#xED;nez-Beamonte R.; Calvo A.C.; Surra J.C.; Manzano R.; Arnal C.; Osta R.; Osada J.; Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice. J Nutr Biochem  2014,25(8),885-892","journal-title":"J Nutr Biochem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3109\/13880209.2015.1042980","volume":"54","author":"Kalaiselvan I.","year":"2016","unstructured":"Kalaiselvan I.; Samuthirapandi M.; Govindaraju A.; Sheeja Malar D.; Kasi P.D.; Olive oil and its phenolic compounds (hydroxytyrosol and tyrosol) ameliorated TCDD-induced heptotoxicity in rats via inhibition of oxidative stress and apoptosis. Pharm Biol  2016,54(2),338-346","journal-title":"Pharm Biol"},{"key":"ref=82","first-page":"277","volume":"23","author":"Rajabian A.","year":"2020","unstructured":"Rajabian A.; Sadeghnia H.; Fanoudi S.; Hosseini A.; Genus Boswellia as a new candidate for neurodegenerative disorders. Iran J Basic Med Sci  2020,23(3),277-286","journal-title":"Iran J Basic Med Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1055\/s-2006-947227","volume":"72","author":"Ammon H.","year":"2006","unstructured":"Ammon H.; Boswellic acids in chronic inflammatory diseases. Planta Med  2006,72(12),1100-1116","journal-title":"Planta Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"112250","DOI":"10.1016\/j.biopha.2021.112250","volume":"144","author":"Siddiqui A.","year":"2021","unstructured":"Siddiqui A.; Shah Z.; Jahan R.N.; Othman I.; Kumari Y.; Mechanistic role of boswellic acids in Alzheimer\u2019s disease: Emphasis on anti-inflammatory properties. Biomed Pharmacother  2021,144,112250","journal-title":"Biomed Pharmacother"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","volume":"46","author":"Minj E.","year":"2021","unstructured":"Minj E.; Upadhayay S.; Mehan S.; Nrf2\/HO-1 signaling activator acetyl-11-keto-beta boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS. Neurochem Res  2021,46(11),2867-2884","journal-title":"Neurochem Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1158\/0008-5472.CAN-06-4699","volume":"67","author":"Landis-Piwowar K.R.","year":"2007","unstructured":"Landis-Piwowar K.R.; Huo C.; Chen D.; Milacic V.; Shi G.; Chan T.H.; Dou Q.P.; A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res  2007,67(9),4303-4310","journal-title":"Cancer Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ncl.2015.07.008","volume":"33","author":"Bedlack R.S.","year":"2015","unstructured":"Bedlack R.S.; Joyce N.; Carter G.T.; Paganoni S.; Karam C.; Complementary and alternative therapies in amyotrophic lateral sclerosis. Neurol Clin  2015,33(4),909-936","journal-title":"Neurol Clin"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0092-8674(93)80066-N","volume":"75","author":"Hockenbery D.M.","year":"1993","unstructured":"Hockenbery D.M.; Oltvai Z.N.; Yin X.M.; Milliman C.L.; Korsmeyer S.J.; Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell  1993,75(2),241-251","journal-title":"Cell"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1006\/abbi.1994.1039","volume":"308","author":"Terao J.","year":"1994","unstructured":"Terao J.; Piskula M.; Yao Q.; Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys  1994,308(1),278-284","journal-title":"Arch Biochem Biophys"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"30574","DOI":"10.1074\/jbc.M202832200","volume":"277","author":"Levites Y.","year":"2002","unstructured":"Levites Y.; Amit T.; Youdim M.B.H.; Mandel S.; Involvement of protein kinase C activation and cell survival\/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem  2002,277(34),30574-30580","journal-title":"J Biol Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000085385","volume":"14","author":"Mandel S.A.","year":"2005","unstructured":"Mandel S.A.; Avramovich-Tirosh Y.; Reznichenko L.; Zheng H.; Weinreb O.; Amit T.; Youdim M.B.H.; Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals  2005,14(1-2),46-60","journal-title":"Neurosignals"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1179\/135100002125000424","volume":"7","author":"Nie G.","year":"2002","unstructured":"Nie G.; Cao Y.; Zhao B.; Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox Rep  2002,7(3),171-177","journal-title":"Redox Rep"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1471-4159.2005.03085.x","volume":"93","author":"Reznichenko L.","year":"2005","unstructured":"Reznichenko L.; Amit T.; Youdim M.B.H.; Mandel S.; Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem  2005,93(5),1157-1167","journal-title":"J Neurochem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1046\/j.1471-4159.2003.02291.x","volume":"88","author":"Mandel S.","year":"2004","unstructured":"Mandel S.; Weinreb O.; Amit T.; Youdim M.B.H.; Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: Implications for neurodegenerative diseases. J Neurochem  2004,88(6),1555-1569","journal-title":"J Neurochem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1179\/147683009X423300","volume":"12","author":"Panickar K.S.","year":"2009","unstructured":"Panickar K.S.; Polansky M.M.; Anderson R.A.; Green tea polyphenols attenuate glial swelling and mitochondrial dysfunction following oxygen-glucose deprivation in cultures. Nutr Neurosci  2009,12(3),105-113","journal-title":"Nutr Neurosci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tox.2004.05.008","volume":"202","author":"Koh S.","year":"2004","unstructured":"Koh S.; Kwon H.; Kim K.S.; Kim J.; Kim M.H.; Yu H.J.; Kim M.; Lee K.W.; Do B.R.; Jung H.K.; Yang K.W.; Appel S.H.; Kim S.H.; Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu\/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals. Toxicology  2004,202(3),213-225","journal-title":"Toxicology"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2005.10.056","volume":"395","author":"Koh S.H.","year":"2006","unstructured":"Koh S.H.; Lee S.M.; Kim H.Y.; Lee K.Y.; Lee Y.J.; Kim H.T.; Kim J.; Kim M.H.; Hwang M.S.; Song C.; Yang K.W.; Lee K.W.; Kim S.H.; Kim O.H.; The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci Lett  2006,395(2),103-107","journal-title":"Neurosci Lett"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s11064-006-9166-z","volume":"31","author":"Xu Z.","year":"2006","unstructured":"Xu Z.; Chen S.; Li X.; Luo G.; Li L.; Le W.; Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res  2006,31(10),1263-1269","journal-title":"Neurochem Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jmgm.2017.04.019","volume":"74","author":"Srinivasan E.","year":"2017","unstructured":"Srinivasan E.; Rajasekaran R.; Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics. J Mol Graph Model  2017,74,288-295","journal-title":"J Mol Graph Model"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0891-5849(96)00351-6","volume":"22","author":"Cao G.","year":"1997","unstructured":"Cao G.; Sofic E.; Prior R.L.; Antioxidant and prooxidant behavior of flavonoids: Structure-activit relationships. Free Radic Biol Med  1997,22(5),749-760","journal-title":"Free Radic Biol Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0197-4580(02)00078-7","volume":"23","author":"Esposito E.","year":"2002","unstructured":"Esposito E.; Rotilio D.; Dimatteo V.; Digiulio C.; Cacchio M.; Algeri S.; A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging  2002,23(5),719-735","journal-title":"Neurobiol Aging"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12263-008-0091-4","volume":"3","author":"Vauzour D.","year":"2008","unstructured":"Vauzour D.; Vafeiadou K.; Rodriguez-Mateos A.; Rendeiro C.; Spencer J.P.E.; The neuroprotective potential of flavonoids: A multiplicity of effects. Genes Nutr  2008,3(3-4),115-126","journal-title":"Genes Nutr"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000485089","volume":"44","author":"He L.","year":"2017","unstructured":"He L.; He T.; Farrar S.; Ji L.; Liu T.; Ma X.; Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol Biochem  2017,44(2),532-553","journal-title":"Cell Physiol Biochem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/antiox9070583","volume":"9","author":"Kim T.Y.","year":"2020","unstructured":"Kim T.Y.; Leem E.; Lee J.M.; Kim S.R.; Control of reactive oxygen species for the prevention of parkinson\u2019s disease: The possible application of flavonoids. Antioxidants  2020,9(7),583","journal-title":"Antioxidants"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3945\/an.114.007500","volume":"6","author":"Solanki I.","year":"2015","unstructured":"Solanki I.; Parihar P.; Mansuri M.L.; Parihar M.S.; Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr  2015,6(1),64-72","journal-title":"Adv Nutr"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s12263-014-0400-z","volume":"9","author":"Mansuri M.L.","year":"2014","unstructured":"Mansuri M.L.; Parihar P.; Solanki I.; Parihar M.S.; Flavonoids in modulation of cell survival signalling pathways. Genes Nutr  2014,9(3),400","journal-title":"Genes Nutr"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/mus.22295","volume":"45","author":"Mantilla C.B.","year":"2012","unstructured":"Mantilla C.B.; Ermilov L.G.; The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission. Muscle Nerve  2012,45(2),274-276","journal-title":"Muscle Nerve"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neulet.2014.02.058","volume":"566","author":"Korkmaz O.T.","year":"2014","unstructured":"Korkmaz O.T.; Aytan N.; Carreras I.; Choi J.K.; Kowall N.W.; Jenkins B.G.; Dedeoglu A.; 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. Neurosci Lett  2014,566,286-291","journal-title":"Neurosci Lett"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuroscience.2016.02.055","volume":"324","author":"Sharma D.R.","year":"2016","unstructured":"Sharma D.R.; Wani W.Y.; Sunkaria A.; Kandimalla R.J.; Sharma R.K.; Verma D.; Bal A.; Gill K.D.; Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus. Neuroscience  2016,324,163-176","journal-title":"Neuroscience"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/protein\/gzx025","volume":"30","author":"Ip P.","year":"2017","unstructured":"Ip P.; Sharda P.R.; Cunningham A.; Chakrabartty S.; Pande V.; Chakrabartty A.; Quercitrin and quercetin 3-&#x3B2;-d-glucoside as chemical chaperones for the A4V SOD1 ALS-causing mutant. Protein Eng Des Sel  2017,30(6),431-440","journal-title":"Protein Eng Des Sel"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2018.03.008","volume":"379","author":"Wang T.H.","year":"2018","unstructured":"Wang T.H.; Wang S.Y.; Wang X.D.; Jiang H.Q.; Yang Y.Q.; Wang Y.; Cheng J.L.; Zhang C.T.; Liang W.W.; Feng H.L.; Fisetin exerts antioxidant and neuroprotective effects in multiple mutant hsod1 models of amyotrophic lateral sclerosis by activating ERK. Neuroscience  2018,379,152-166","journal-title":"Neuroscience"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.foodchem.2014.09.090","volume":"172","author":"Ye L.","year":"2015","unstructured":"Ye L.; Wang H.; Duncan S.E.; Eigel W.N.; O\u2019Keefe S.F.; Antioxidant activities of Vine Tea (Ampelopsis grossedentata) extract and its major component dihydromyricetin in soybean oil and cooked ground beef. Food Chem  2015,172,416-422","journal-title":"Food Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/biof.552210136","volume":"21","author":"Murakami T.","year":"2004","unstructured":"Murakami T.; Miyakoshi M.; Araho D.; Mizutani K.; Kambara T.; Ikeda T.; Chou W.H.; Inukai M.; Takenaka A.; Igarashi K.; Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors  2004,21(1-4),175-178","journal-title":"Biofactors"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/ptr.3671","volume":"26","author":"Kou X.","year":"2012","unstructured":"Kou X.; Shen K.; An Y.; Qi S.; Dai W.X.; Yin Z.; Ampelopsin inhibits H2O2-induced apoptosis by ERK and Akt signaling pathways and up-regulation of heme oxygenase-1. Phytother Res  2012,26(7),988-994","journal-title":"Phytother Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.fitote.2008.05.007","volume":"79","author":"Singh B.","year":"2008","unstructured":"Singh B.; Kaur P.; Gopichand; Singh, R.D.; Ahuja, P.S. Biology and chemistry of Ginkgo biloba. Fitoterapia  2008,79(6),401-418","journal-title":"Fitoterapia"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1385\/JMN:17:1:89","volume":"17","author":"Ferrante R.J.","year":"2001","unstructured":"Ferrante R.J.; Klein A.M.; Dedeoglu A.; Beal M.F.; Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis. J Mol Neurosci  2001,17(1),89-96","journal-title":"J Mol Neurosci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0022-510X(00)00421-4","volume":"180","author":"Jiang F.","year":"2000","unstructured":"Jiang F.; DeSilva S.; Turnbull J.; Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice. J Neurol Sci  2000,180(1-2),52-54","journal-title":"J Neurol Sci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1006\/bbrc.1999.0577","volume":"258","author":"Trieu V.N.","year":"1999","unstructured":"Trieu V.N.; Uckun F.M.; Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun  1999,258(3),685-688","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002829.pub2","author":"Orrell R.","year":"2004","unstructured":"Orrell R.; Lane J.; Ross M.;  In: Cochrane Database of Systematic Reviews  2004","journal-title":"In: Cochrane Database of Systematic Reviews"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ana.410390203","volume":"39","author":"Gurney M.E.","year":"1996","unstructured":"Gurney M.E.; Cutting F.B.; Zhai P.; Doble A.; Taylor C.P.; Andrus P.K.; Hall E.D.; Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol  1996,39(2),147-157","journal-title":"Ann Neurol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/146608201300079364","volume":"2","author":"Desnuelle C.","year":"2001","unstructured":"Desnuelle C.; Dib M.; Garrel C.; Favier A.; A double-blind, placebo-controlled randomized clinical trial of &#x3B1;-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord  2001,2(1),9-18","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.20316","volume":"57","author":"Ascherio A.","year":"2005","unstructured":"Ascherio A.; Weisskopf M.G.; O\u2019Reilly E.J.; Jacobs E.J.; McCullough M.L.; Calle E.E.; Cudkowicz M.; Thun M.J.; Vitamin E.; Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol  2005,57(1),104-110","journal-title":"Ann Neurol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jnnp.2005.083378","volume":"78","author":"Veldink J.H.","year":"2006","unstructured":"Veldink J.H.; Kalmijn S.; Groeneveld G-J.; Wunderink W.; Koster A.; de Vries J.H.M.; van der Luyt J.; Wokke J.H.J.; Van den Berg L.H.; Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry  2006,78(4),367-371","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/aje\/kwq416","volume":"173","author":"Wang H.","year":"2011","unstructured":"Wang H.; O\u2019Reilly E.J.; Weisskopf M.G.; Logroscino G.; McCullough M.L.; Schatzkin A.; Kolonel L.N.; Ascherio A.; Vitamin E.; Vitamin E intake and risk of amyotrophic lateral sclerosis: A pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol  2011,173(6),595-602","journal-title":"Am J Epidemiol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00702-004-0220-1","volume":"112","author":"Graf M.","year":"2005","unstructured":"Graf M.; Ecker D.; Horowski R.; Kramer B.; Riederer P.; Gerlach M.; Hager C.; Ludolph A.C.; Becker G.; Osterhage J.; Jost W.H.; Schrank B.; Stein C.; Kostopulos P.; Lubik S.; Wekwerth K.; Dengler R.; Troeger M.; Wuerz A.; Hoge A.; Schrader C.; Schimke N.; Krampfl K.; Petri S.; Zierz S.; Eger K.; Neudecker S.; Traufeller K.; Sievert M.; Neund&#xF6;rfer B.; Hecht M.; High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: Results of a placebo-controlled double-blind study. J Neural Transm  2005,112(5),649-660","journal-title":"J Neural Transm"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/21678421.2012.745570","volume":"14","author":"Michal Freedman D.","year":"2013","unstructured":"Michal Freedman D.; Kuncl R.W.; Weinstein S.J.; Malila N.; Virtamo J.; Albanes D.; Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener  2013,14(4),246-251","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s10072-006-0668-x","volume":"27","author":"Galbussera A.","year":"2006","unstructured":"Galbussera A.; Tremolizzo L.; Brighina L.; Testa D.; Lovati R.; Ferrarese C.; Cavaletti G.; Filippini G.; Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: A follow-up case series study. Neurol Sci  2006,27(3),190-193","journal-title":"Neurol Sci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000026258","volume":"19","author":"Longnecker M.P.","year":"2000","unstructured":"Longnecker M.P.; Kamel F.; Umbach D.M.; Munsat T.L.; Shefner J.M.; Lansdell L.W.; Sandler D.P.; Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology  2000,19(4),210-216","journal-title":"Neuroepidemiology"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jamaneurol.2016.3401","volume":"73","author":"Nieves J.W.","year":"2016","unstructured":"Nieves J.W.; Gennings C.; Factor-Litvak P.; Hupf J.; Singleton J.; Sharf V.; Oskarsson B.; Fernandes Filho J.A.M.; Sorenson E.J.; D\u2019Amico E.; Goetz R.; Mitsumoto H.; Association between dietary intake and function in amyotrophic lateral sclerosis. JAMA Neurol  2016,73(12),1425-1432","journal-title":"JAMA Neurol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.23820","volume":"73","author":"Fitzgerald K.C.","year":"2013","unstructured":"Fitzgerald K.C.; O\u2019Reilly &#xC9;.J.; Fondell E.; Falcone G.J.; McCullough M.L.; Park Y.; Kolonel L.N.; Ascherio A.; Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies. Ann Neurol  2013,73(2),236-245","journal-title":"Ann Neurol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000201563","volume":"32","author":"Okamoto K.","year":"2009","unstructured":"Okamoto K.; Kihira T.; Kobashi G.; Washio M.; Sasaki S.; Yokoyama T.; Miyake Y.; Sakamoto N.; Inaba Y.; Nagai M.; Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan. Neuroepidemiology  2009,32(4),251-256","journal-title":"Neuroepidemiology"},{"key":"ref=132","first-page":"303","volume":"22","author":"Ma Z.","year":"1999","unstructured":"Ma Z.; Yang Z.; Scavenging effects of Astragalus and Gynostemma pentaphyllum with its product on O2-. and. OH. Zhong Yao Cai  1999,22(6),303-306","journal-title":"Zhong Yao Cai"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2174\/1389450116666150907104742","volume":"17","author":"Shahzad M.","year":"2016","unstructured":"Shahzad M.; Shabbir A.; Wojcikowski K.; Wohlmuth H.; Gobe G.C.; The antioxidant effects of radix astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease. Curr Drug Targets  2016,17(12),1331-1340","journal-title":"Curr Drug Targets"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3892\/ijmm.21.4.405","volume":"21","author":"Rong J.","year":"2008","unstructured":"Rong J.; Cheung C.; Lau A.; Shen J.; Tam P.; Cheng Y.C.; Induction of heme oxygenase-1 by traditional Chinese medicine formulation ISF-1 and its ingredients as a cytoprotective mechanism against oxidative stress. Int J Mol Med  2008,21(4),405-411","journal-title":"Int J Mol Med"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1440-1681.2008.05059.x","volume":"36","author":"Hu J.Y.","year":"2009","unstructured":"Hu J.Y.; Han J.; Chu Z.G.; Song H.P.; Zhang D.X.; Zhang Q.; Huang Y.S.; Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels. Clin Exp Pharmacol Physiol  2009,36(4),351-357","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3892\/ijmm.2017.3157","volume":"40","author":"Liu X.","year":"2017","unstructured":"Liu X.; Zhang J.; Wang S.; Qiu J.; Yu C.; Astragaloside I.V.; Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting &#x3B1;-synuclein expression via the p38 MAPK pathway. Int J Mol Med  2017,40(6),1772-1780","journal-title":"Int J Mol Med"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5114\/fn.2019.86299","volume":"57","author":"Yu J.","year":"2019","unstructured":"Yu J.; Guo M.; Li Y.; Zhang H.; Chai Z.; Wang Q.; Yan Y.; Yu J.; Liu C.; Zhang G.; Cungen M.; Astragaloside IV protects neurons from microglia-mediated cell damage through promoting microglia polarization. Folia Neuropathol  2019,57(2),170-181","journal-title":"Folia Neuropathol"},{"key":"ref=138","first-page":"718","volume":"37","author":"Liu Y.","year":"2006","unstructured":"Liu Y.; Therapeutic potential of madecassoside in transgenic mice of amyotrophic lateral sclerosis. Chin Tradit Herbal Drugs  2006,37,718-720","journal-title":"Chin Tradit Herbal Drugs"},{"key":"ref=139","first-page":"2297","volume":"28","author":"Bai J-R.","year":"2008","unstructured":"Bai J-R.; Liu Y-J.; Song Y.; The mechanism of interfere effects of madecassoside (MC) on neurodegeneration in mice. Zhongguo Laonianxue Zazhi  2008,28,2297-2300","journal-title":"Zhongguo Laonianxue Zazhi"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3892\/ijmm.2018.3479","volume":"41","author":"Sasmita A.O.","year":"2018","unstructured":"Sasmita A.O.; Ling A.P.K.; Voon K.G.L.; Koh R.Y.; Wong Y.P.; Madecassoside activates anti neuroinflammatory mechanisms by inhibiting lipopolysaccharide induced microglial inflammation. Int J Mol Med  2018,41(5),3033-3040","journal-title":"Int J Mol Med"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"134386","DOI":"10.1016\/j.neulet.2019.134386","volume":"709","author":"Liu S.","year":"2019","unstructured":"Liu S.; Li G.; Tang H.; Pan R.; Wang H.; Jin F.; Yan X.; Xing Y.; Chen G.; Fu Y.; Dong J.; Madecassoside ameliorates lipopolysaccharide-induced neurotoxicity in rats by activating the Nrf2-HO-1 pathway. Neurosci Lett  2019,709,134386","journal-title":"Neurosci Lett"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/molecules24102020","volume":"24","author":"Lee K.","year":"2019","unstructured":"Lee K.; Choi J.; Choi B.K.; Gu Y.M.; Ryu H.W.; Oh S.R.; Lee H.J.; Picroside I.I.; Picroside II.; Isolated from Pseudolysimachion rotundum var. subintegrum inhibits glucocorticoid refractory serum amyloid A (SAA) Expression and SAA-induced IL-33 secretion. Molecules  2019,24(10),2020","journal-title":"Molecules"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1177\/1934578X19856526","author":"Li B.","year":"2019","unstructured":"Li B.; Lei S.; Xiong S.; Chen S.; Zhang Z.; Pharmacokinetics and pharmacodynamics of morroniside: A review. Nat Prod Commun  2019,2019","journal-title":"Nat Prod Commun"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10571-007-9168-7","volume":"28","author":"Wang W.","year":"2008","unstructured":"Wang W.; Huang W.; Li L.; Ai H.; Sun F.; Liu C.; An Y.; Morroniside prevents peroxide-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells. Cell Mol Neurobiol  2008,28(2),293-305","journal-title":"Cell Mol Neurobiol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2009.04.013","volume":"613","author":"Wang W.","year":"2009","unstructured":"Wang W.; Sun F.; An Y.; Ai H.; Zhang L.; Huang W.; Li L.; Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity. Eur J Pharmacol  2009,613(1-3),19-23","journal-title":"Eur J Pharmacol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.brainresbull.2010.07.003","volume":"83","author":"Wang W.","year":"2010","unstructured":"Wang W.; Xu J.; Li L.; Wang P.; Ji X.; Ai H.; Zhang L.; Li L.; Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res Bull  2010,83(5),196-201","journal-title":"Brain Res Bull"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/ijmm.2017.2882","volume":"39","author":"Zhang J.X.","year":"2017","unstructured":"Zhang J.X.; Wang R.; Xi J.; Shen L.; Zhu A.Y.; Qi Q.; Wang Q.Y.; Zhang L.J.; Wang F.C.; L&#xFC; H.Z.; Hu J.G.; Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage. Int J Mol Med  2017,39(3),603-612","journal-title":"Int J Mol Med"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1248\/bpb.23.890","volume":"23","author":"Li P.","year":"2000","unstructured":"Li P.; Matsunaga K.; Ohizumi Y.; Nerve growth factor-potentiating compounds from Picrorhizae Rhizoma. Biol Pharm Bull  2000,23(7),890-892","journal-title":"Biol Pharm Bull"},{"key":"ref=149","first-page":"573","volume":"59","author":"Cao Y.","year":"2007","unstructured":"Cao Y.; Liu J.W.; Yu Y.J.; Zheng P.Y.; Zhang X.D.; Li T.; Guo M.C.; Synergistic protective effect of picroside II and NGF on PC12 cells against oxidative stress induced by H2O2. Pharmacol Rep  2007,59(5),573-579","journal-title":"Pharmacol Rep"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ptr.6591","volume":"34","author":"Guo N.","year":"2020","unstructured":"Guo N.; Jin C.; Shen L.; Wu F.; Lin X.; Feng Y.; Chemical components, pharmacological actions, and clinical applications of Rhizoma picrorhizae. Phytother Res  2020,34(5),1071-1082","journal-title":"Phytother Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1142\/S0192415X0700517X","volume":"35","author":"Li T.","year":"2007","unstructured":"Li T.; Liu J.W.; Zhang X.D.; Guo M.C.; Ji G.; The neuroprotective effect of picroside II from hu-huang-lian against oxidative stress. Am J Chin Med  2007,35(4),681-691","journal-title":"Am J Chin Med"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.3390\/molecules26237186","volume":"26","author":"Gong X.","year":"2021","unstructured":"Gong X.; Su X.; Liu H.; Diallyl trisulfide, the antifungal component of garlic essential oil and the bioactivity of its nanoemulsions formed by spontaneous emulsification. Molecules  2021,26(23),7186","journal-title":"Molecules"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/ajh.2010.130","volume":"23","author":"Cal&#xF2; L.A.","year":"2010","unstructured":"Cal&#xF2; L.A.; Fusaro M.; Davis P.A.; HO-1 attenuates hypertension-induced inflammation\/oxidative stress: Support from Bartter\u2019s\/Gitelman\u2019s patients. Am J Hypertens  2010,23(9),936-936","journal-title":"Am J Hypertens"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1179\/174313208X332959","volume":"31","author":"Sun M.M.","year":"2009","unstructured":"Sun M.M.; Bu H.; Li B.; Yu J.X.; Guo Y.S.; Li C.Y.; Neuroprotective potential of phase II enzyme inducer diallyl trisulfide. Neurol Res  2009,31(1),23-27","journal-title":"Neurol Res"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.brainres.2010.12.014","volume":"1374","author":"Guo Y.","year":"2011","unstructured":"Guo Y.; Zhang K.; Wang Q.; Li Z.; Yin Y.; Xu Q.; Duan W.; Li C.; Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Brain Res  2011,1374,110-115","journal-title":"Brain Res"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s11064-018-2651-3","volume":"43","author":"Liu C.","year":"2018","unstructured":"Liu C.; Leng B.; Li Y.; Jiang H.; Duan W.; Guo Y.; Li C.; Hong K.; Diallyl trisulfide protects motor neurons from the neurotoxic protein TDP-43 via activating lysosomal degradation and the antioxidant response. Neurochem Res  2018,43(12),2304-2312","journal-title":"Neurochem Res"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/antiox8090410","volume":"8","author":"Silva-Islas C.A.","year":"2019","unstructured":"Silva-Islas C.A.; Ch&#xE1;nez-C&#xE1;rdenas M.E.; Barrera-Oviedo D.; Ortiz-Plata A.; Pedraza-Chaverri J.; Maldonado P.D.; Diallyl trisulfide protects rat brain tissue against the damage induced by ischemia-reperfusion through the Nrf2 pathway. Antioxidants  2019,8(9),410","journal-title":"Antioxidants"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.biopha.2017.09.135","volume":"96","author":"Zhu J.","year":"2017","unstructured":"Zhu J.; Shen L.; Lin X.; Hong Y.; Feng Y.; Clinical research on traditional chinese medicine compounds and their preparations for amyotrophic lateral sclerosis. Biomed Pharmacother  2017,96,854-864","journal-title":"Biomed Pharmacother"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42485-019-00009-7","volume":"2019","author":"Kumar V.","year":"2019","unstructured":"Kumar V.; Gupta P.; Hassan M.I.; Mechanism and implications of traditional chinese medicine in amyotrophic lateral sclerosis therapy. J Proteins Proteomics  2019,2019,1-17","journal-title":"J Proteins Proteomics"},{"key":"ref=160","first-page":"537","volume":"77","author":"Komine O.","year":"2015","unstructured":"Komine O.; Yamanaka K.; Neuroinflammation in motor neuron disease. Nagoya J Med Sci  2015,77(4),537-549","journal-title":"Nagoya J Med Sci"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","volume":"12","author":"Hooten K.G.","year":"2015","unstructured":"Hooten K.G.; Beers D.R.; Zhao W.; Appel S.H.; Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics  2015,12(2),364-375","journal-title":"Neurotherapeutics"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"Liu J.","year":"2017","unstructured":"Liu J.; Wang F.; Role of neuroinflammation in amyotrophic lateral sclerosis: Cellular mechanisms and therapeutic implications. Front Immunol  2017,8,1005","journal-title":"Front Immunol"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.2174\/092986708785133031","volume":"15","author":"S&#xFC;ssmuth S.","year":"2008","unstructured":"S&#xFC;ssmuth S.; Brettschneider J.; Ludolph A.; Tumani H.; Biochemical markers in CSF of ALS patients. Curr Med Chem  2008,15(18),1788-1801","journal-title":"Curr Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","volume":"10","author":"Philips T.","year":"2011","unstructured":"Philips T.; Robberecht W.; Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol  2011,10(3),253-263","journal-title":"Lancet Neurol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1381612823666170615110446","volume":"23","author":"Peric M.","year":"2018","unstructured":"Peric M.; Mitrecic D.; Andjus P.R.; Targeting astrocytes for treatment in amyotrophic lateral sclerosis. Curr Pharm Des  2018,23(33),23","journal-title":"Curr Pharm Des"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"767041","DOI":"10.3389\/fnmol.2021.767041","volume":"14","author":"Liu E.","year":"2021","unstructured":"Liu E.; Karpf L.; Bohl D.; Neuroinflammation in amyotrophic lateral sclerosis and frontotemporal dementia and the interest of induced pluripotent stem cells to study immune cells interactions with neurons. Front Mol Neurosci  2021,14,767041","journal-title":"Front Mol Neurosci"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.brainres.2009.05.009","volume":"1282","author":"Yang C.","year":"2009","unstructured":"Yang C.; Zhang X.; Fan H.; Liu Y.; Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res  2009,1282,133-141","journal-title":"Brain Res"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4933-7-1","volume":"7","author":"Sikora E.","year":"2010","unstructured":"Sikora E.; Scapagnini G.; Barbagallo M.; Curcumin, inflammation, ageing and age-related diseases. Immun Ageing  2010,7(1),1","journal-title":"Immun Ageing"},{"key":"ref=169","doi-asserted-by":"publisher","DOI":"10.20455\/ros.2016.861","volume":"2","author":"Chico L.","year":"2016","unstructured":"Chico L.; Ienco E.; Bisordi C.; Gerfo A.; Schirinzi E.; Siciliano G.; Curcumin as an ROS scavenger in amyotrophic lateral sclerosis. React Oxyg Species  2016,2(5)","journal-title":"React Oxyg Species"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/21678421.2018.1440738","volume":"19","author":"Bedlack R.","year":"2018","unstructured":"Bedlack R.; ALSUntangled 44: curcumin. Amyotroph Lateral Scler Frontotemporal Degener  2018,19(7-8),623-629","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/1028415X.2020.1760531","volume":"25","author":"Adami R.","year":"2022","unstructured":"Adami R.; Bottai D.; Curcumin and neurological diseases. Nutr Neurosci  2022,25(3),441-461","journal-title":"Nutr Neurosci"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.intimp.2004.08.008","volume":"5","author":"Bi X.L.","year":"2005","unstructured":"Bi X.L.; Yang J.Y.; Dong Y.X.; Wang J.M.; Cui Y.H.; Ikeshima T.; Zhao Y.Q.; Wu C.F.; Resveratrol inhibits nitric oxide and TNF-&#x3B1; production by lipopolysaccharide-activated microglia. Int Immunopharmacol  2005,5(1),185-193","journal-title":"Int Immunopharmacol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cbi.2008.04.015","volume":"174","author":"Meng X.L.","year":"2008","unstructured":"Meng X.L.; Yang J.Y.; Chen G.L.; Wang L.H.; Zhang L.J.; Wang S.; Li J.; Wu C.F.; Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships. Chem Biol Interact  2008,174(1),51-59","journal-title":"Chem Biol Interact"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/ajh.2010.87","volume":"23","author":"Morita T.","year":"2010","unstructured":"Morita T.; Celastrol: A new therapeutic potential of traditional Chinese medicine. Am J Hypertens  2010,23(8),821-821","journal-title":"Am J Hypertens"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"ftw059","DOI":"10.1093\/femspd\/ftw059","volume":"74","author":"Venkatesha S.H.","year":"2016","unstructured":"Venkatesha S.H.; Dudics S.; Astry B.; Moudgil K.D.; Control of autoimmune inflammation by celastrol, a natural triterpenoid. Pathog Dis  2016,74(6),ftw059","journal-title":"Pathog Dis"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000090364","volume":"2","author":"Kiaei M.","year":"2005","unstructured":"Kiaei M.; Kipiani K.; Petri S.; Chen J.; Calingasan N.Y.; Beal M.F.; Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis  2005,2(5),246-254","journal-title":"Neurodegener Dis"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/emm.2007.78","volume":"39","author":"Jung H.W.","year":"2007","unstructured":"Jung H.W.; Chung Y.S.; Kim Y.S.; Park Y.K.; Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-&#x3BA;B in LPS-stimulated BV-2 microglial cells. Exp Mol Med  2007,39(6),715-721","journal-title":"Exp Mol Med"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1002\/jcp.25703","volume":"232","author":"Zhang R.","year":"2017","unstructured":"Zhang R.; Zhu Y.; Dong X.; Liu B.; Zhang N.; Wang X.; Liu L.; Xu C.; Huang S.; Chen L.; Celastrol attenuates cadmium-induced neuronal apoptosis via inhibiting Ca2+-CaMKII-Dependent Akt\/mTOR pathway. J Cell Physiol  2017,232(8),2145-2157","journal-title":"J Cell Physiol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s10753-015-0265-3","volume":"39","author":"Jin X.","year":"2016","unstructured":"Jin X.; Wang J.; Xia Z.M.; Shang C.H.; Chao Q.L.; Liu Y.R.; Fan H.Y.; Chen D.Q.; Qiu F.; Zhao F.; Anti-inflammatory and anti-oxidative activities of paeonol and its metabolites through blocking MAPK\/ERK\/p38 signaling pathway. Inflammation  2016,39(1),434-446","journal-title":"Inflammation"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1055\/s-0030-1271033","volume":"77","author":"Wang X.","year":"2011","unstructured":"Wang X.; Zhu G.; Yang S.; Wang X.; Cheng H.; Wang F.; Li X.; Li Q.; Paeonol prevents excitotoxicity in rat pheochromocytoma PC12 cells via downregulation of ERK activation and inhibition of apoptosis. Planta Med  2011,77(15),1695-1701","journal-title":"Planta Med"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/SHK.0b013e31823fe939","volume":"37","author":"Tseng Y.T.","year":"2012","unstructured":"Tseng Y.T.; Hsu Y.Y.; Shih Y.T.; Lo Y.C.; Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons. Shock  2012,37(3),312-318","journal-title":"Shock"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1007\/s10753-016-0426-z","volume":"39","author":"He L.X.","year":"2016","unstructured":"He L.X.; Tong X.; Zeng J.; Tu Y.; Wu S.; Li M.; Deng H.; Zhu M.; Li X.; Nie H.; Yang L.; Huang F.; Paeonol suppresses neuroinflammatory responses in LPS-activated microglia cells. Inflammation  2016,39(6),1904-1917","journal-title":"Inflammation"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"103586","DOI":"10.1016\/j.bioorg.2020.103586","volume":"96","author":"Vu V.T.","year":"2020","unstructured":"Vu V.T.; Liu X.Q.; Nguyen M.T.; Lin Y.L.; Kong L.Y.; Luo J.G.; New obovatol trimeric neolignans with NO inhibitory activity from the leaves of Magnolia officinalis var. biloba. Bioorg Chem  2020,96,103586","journal-title":"Bioorg Chem"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/j.1476-5381.2010.00659.x","volume":"159","author":"Ock J.","year":"2010","unstructured":"Ock J.; Han H.S.; Hong S.H.; Lee S.Y.; Han Y.M.; Kwon B.M.; Suk K.; Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation. Br J Pharmacol  2010,159(8),1646-1662","journal-title":"Br J Pharmacol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s11064-020-02971-x","volume":"45","author":"Liu J.","year":"2020","unstructured":"Liu J.; Su G.; Gao J.; Tian Y.; Liu X.; Zhang Z.; Effects of peroxiredoxin 2 in neurological disorders: A review of its molecular mechanisms. Neurochem Res  2020,45(4),720-730","journal-title":"Neurochem Res"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.intimp.2009.09.010","volume":"9","author":"Yuan D.","year":"2009","unstructured":"Yuan D.; Ma B.; Yang J.; Xie Y.; Wang L.; Zhang L.; Kano Y.; Wu C.; Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism. Int Immunopharmacol  2009,9(13-14),1549-1554","journal-title":"Int Immunopharmacol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.03-0057fje","volume":"17","author":"Lee H.","year":"2003","unstructured":"Lee H.; Kim Y.O.; Kim H.; Kim S.Y.; Noh H.S.; Kang S.S.; Cho G.J.; Choi W.S.; Suk K.; Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J  2003,17(13),1-21","journal-title":"FASEB J"},{"key":"ref=188","first-page":"467","volume":"19","author":"Du Z.Y.","year":"1998","unstructured":"Du Z.Y.; Li X.Y.; Inhibitory effects of ginkgolides on nitric oxide production in neonatal rat microglia in vitro. Chung Kuo Yao Li Hsueh Pao  1998,19(5),467-470","journal-title":"Chung Kuo Yao Li Hsueh Pao"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"627846","DOI":"10.3389\/fncel.2020.627846","volume":"14","author":"Wang L.","year":"2021","unstructured":"Wang L.; Lei Q.; Zhao S.; Xu W.; Dong W.; Ran J.; Shi Q.; Fu J.; Ginkgolide B.; Ginkgolide B maintains calcium homeostasis in hypoxic hippocampal neurons by inhibiting calcium influx and intracellular calcium release. Front Cell Neurosci  2021,14,627846","journal-title":"Front Cell Neurosci"},{"key":"ref=190","first-page":"12","author":"Huang L.","year":"2021","unstructured":"Huang L.; Shi Y.; Zhao L.; Ginkgolide B.; Alleviates learning and memory impairment in rats with vascular dementia by reducing neuroinflammation via regulating NF-\u2096B pathway. Front Pharmacol  2021,12","journal-title":"Front Pharmacol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3892\/etm.2021.10018","volume":"21","author":"Sun M.","year":"2021","unstructured":"Sun M.; Sheng Y.; Zhu Y.; Ginkgolide B.; Ginkgolide B alleviates the inflammatory response and attenuates the activation of LPS induced BV2 cells in vitro and in vivo. Exp Ther Med  2021,21(6),586","journal-title":"Exp Ther Med"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fneur.2018.00039","volume":"9","author":"Briones M.R.S.","year":"2018","unstructured":"Briones M.R.S.; Snyder A.M.; Ferreira R.C.; Neely E.B.; Connor J.R.; Broach J.R.; A possible role for platelet-activating factor receptor in amyotrophic lateral sclerosis treatment. Front Neurol  2018,9,39","journal-title":"Front Neurol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejphar.2010.02.011","volume":"633","author":"Ko H.M.","year":"2010","unstructured":"Ko H.M.; Koppula S.; Kim B.W.; Kim I.S.; Hwang B.Y.; Suk K.; Park E.J.; Choi D.K.; Inflexin attenuates proinflammatory responses and nuclear factor-&#x3BA;B activation in LPS-treated microglia. Eur J Pharmacol  2010,633(1-3),98-106","journal-title":"Eur J Pharmacol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neulet.2010.08.064","volume":"485","author":"Ha S.K.","year":"2010","unstructured":"Ha S.K.; Moon E.; Kim S.Y.; Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-&#x3BA;B and JNK activations in microglia cells. Neurosci Lett  2010,485(3),143-147","journal-title":"Neurosci Lett"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00232-004-0731-6","volume":"203","author":"Grewer C.","year":"2005","unstructured":"Grewer C.; Rauen T.; Electrogenic glutamate transporters in the CNS: molecular mechanism, pre-steady-state kinetics, and their impact on synaptic signaling. J Membr Biol  2005,203(1),1-20","journal-title":"J Membr Biol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/ars.2009.2444","volume":"11","author":"Foran E.","year":"2009","unstructured":"Foran E.; Trotti D.; Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal  2009,11(7),1587-1602","journal-title":"Antioxid Redox Signal"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0079-6123(08)60767-0","volume":"100","author":"Choi D.W.","year":"1994","unstructured":"Choi D.W.; Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res  1994,100,47-51","journal-title":"Prog Brain Res"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2174\/092986710791163939","volume":"17","author":"Cheah B.C.","year":"2010","unstructured":"Cheah B.C.; Vucic S.; Krishnan A.; Kiernan M.C.; Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem  2010,17(18),1942-1959","journal-title":"Curr Med Chem"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.410280106","volume":"28","author":"Rothstein J.D.","year":"1990","unstructured":"Rothstein J.D.; Tsai G.; Kuncl R.W.; Clawson L.; Cornblath D.R.; Drachman D.B.; Pestronk A.; Stauch B.L.; Coyle J.T.; Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol  1990,28(1),18-25","journal-title":"Ann Neurol"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0361-9230(93)90269-H","volume":"30","author":"Plaitakis A.","year":"1993","unstructured":"Plaitakis A.; Constantakakis E.; Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartylglutamate in amyotrophic lateral sclerosis. Brain Res Bull  1993,30(3-4),381-386","journal-title":"Brain Res Bull"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1212\/WNL.56.2.270","volume":"56","author":"Ferrarese C.","year":"2001","unstructured":"Ferrarese C.; Sala G.; Riva R.; Begni B.; Zoia C.; Tremolizzo L.; Galimberti G.; Millul A.; Bastone A.; Mennini T.; Balzarini C.; Frattola L.; Beghi E.; Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology  2001,56(2),270-272","journal-title":"Neurology"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0024-3205(02)01729-0","volume":"71","author":"Cho J.","year":"2002","unstructured":"Cho J.; Ho Kim Y.; Kong J.Y.; Ha Yang; C.; Gook Park, C. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. Life Sci  2002,71(5),591-599","journal-title":"Life Sci"},{"key":"ref=203","first-page":"436","volume":"30","author":"Chen Y.Z.","year":"2007","unstructured":"Chen Y.Z.; Wang Q.W.; Liang Y.; Fang Y.Q.; Protective effects of beta-asarone on cultured rat cortical neurons damage induced by glutamate. Zhong Yao Cai  2007,30(4),436-439","journal-title":"Zhong Yao Cai"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.toxicon.2003.10.017","volume":"43","author":"Jiang B.","year":"2004","unstructured":"Jiang B.; Liu J.H.; Bao Y.M.; An L.J.; Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Toxicon  2004,43(1),53-59","journal-title":"Toxicon"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/00001756-199703030-00029","volume":"8","author":"Ved H.S.","year":"1997","unstructured":"Ved H.S.; Koenig M.L.; Dave J.R.; Doctor B.P.; Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuroreport  1997,8(4),963-967","journal-title":"Neuroreport"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/jat.805","volume":"21","author":"Gordon R.K.","year":"2001","unstructured":"Gordon R.K.; Nigam S.V.; Weitz J.A.; Dave J.R.; Doctor B.P.; Ved H.S.; The NMDA receptor ion channel: A site for binding of huperzine A. J Appl Toxicol  2001,21(S1),S47-S51","journal-title":"J Appl Toxicol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF03033367","volume":"13","author":"Hemendinger R.A.","year":"2008","unstructured":"Hemendinger R.A.; Armstrong E.J.; Persinski R.; Todd J.; Mougeot J.L.; Volvovitz F.; Rosenfeld J.; Huperzine a provides neuroprotection against several cell death inducers using in vitro model systems of motor neuron cell death. Neurotox Res  2008,13(1),49-61","journal-title":"Neurotox Res"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00210-009-0470-4","volume":"381","author":"Wang C.J.","year":"2010","unstructured":"Wang C.J.; Hu C.P.; Xu K.P.; Yuan Q.; Li F.S.; Zou H.; Tan G.S.; Li Y.J.; Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells. Naunyn Schmiedebergs Arch Pharmacol  2010,381(1),73-81","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00221-008-1600-9","volume":"193","author":"Zhang F.","year":"2009","unstructured":"Zhang F.; Zheng W.; Pi R.; Mei Z.; Bao Y.; Gao J.; Tang W.; Chen S.; Liu P.; Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase\/Akt signaling pathway. Exp Brain Res  2009,193(1),109-118","journal-title":"Exp Brain Res"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1074\/jbc.M410508200","volume":"280","author":"Kanekura K.","year":"2005","unstructured":"Kanekura K.; Hashimoto Y.; Kita Y.; Sasabe J.; Aiso S.; Nishimoto I.; Matsuoka M.A.; Rac1\/phosphatidylinositol 3-kinase\/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu\/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J Biol Chem  2005,280(6),4532-4543","journal-title":"J Biol Chem"},{"key":"ref=211","first-page":"300","volume":"18","author":"Chang M.X.","year":"1993","unstructured":"Chang M.X.; Xu L.Y.; Tao J.S.; Feng Y.; Metabolism and pharmacokinetics of ferulic acid in rats. Zhongguo Zhongyao Zazhi  1993,18(5),300-302, 319","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/j.1745-7254.2007.00634.x","volume":"28","author":"Jin Y.","year":"2007","unstructured":"Jin Y.; Yan E.; Fan Y.; Guo X.; Zhao Y.; Zong Z.; Liu Z.; Neuroprotection by sodium ferulate against glutamate-induced apoptosis is mediated by ERK and PI3 kinase pathways. Acta Pharmacol Sin  2007,28(12),1881-1890","journal-title":"Acta Pharmacol Sin"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3892\/ijmm.2017.3127","volume":"40","author":"Ren Z.","year":"2017","unstructured":"Ren Z.; Zhang R.; Li Y.; Li Y.; Yang Z.; Yang H.; Ferulic acid exerts neuroprotective effects against cerebral ischemia\/reperfusion-induced injury via antioxidant and anti-apoptotic mechanisms in vitro and in vivo. Int J Mol Med  2017,40(5),1444-1456","journal-title":"Int J Mol Med"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/molecules26010090","volume":"26","author":"Nakayama H.","year":"2020","unstructured":"Nakayama H.; Nakahara M.; Matsugi E.; Soda M.; Hattori T.; Hara K.; Usami A.; Kusumoto C.; Higashiyama S.; Kitaichi K.; Protective effect of ferulic acid against hydrogen peroxide induced apoptosis in PC12 cells. Molecules  2020,26(1),90","journal-title":"Molecules"},{"key":"ref=215","first-page":"84","volume":"6","author":"Yingzhu CHEN.","year":"1988","unstructured":"Yingzhu CHEN.; Yongjian GU.; Shiyao BAO.; Protective effects of acanthopanax senticousus saponins on cortical neuronal ischemia-hypoxia injury. J Clin Neurol  1988,6,84-87","journal-title":"J Clin Neurol"},{"key":"ref=216","first-page":"398","volume":"32","author":"Diao H-X.","year":"2009","unstructured":"Diao H-X.; Song S-L.; Liang H.; Wang Y-S.; Wang W-L.; Ji A-G.; Protective effect of polysaccharides from sea cucumber on glu-induced neurotoxicity in PC12 cells. Zhong Yao Cai  2009,32(3),398-400","journal-title":"Zhong Yao Cai"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.nbd.2007.07.002","volume":"28","author":"Guatteo E.","year":"2007","unstructured":"Guatteo E.; Carunchio I.; Pieri M.; Albo F.; Canu N.; Mercuri N.B.; Zona C.; Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels\u2019 activation in a genetic model of amyotrophic lateral sclerosis. Neurobiol Dis  2007,28(1),90-100","journal-title":"Neurobiol Dis"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0022-510X(00)00414-7","volume":"180","author":"Van Den Bosch L.","year":"2000","unstructured":"Van Den Bosch L.; Vandenberghe W.; Klaassen H.; Van Houtte E.; Robberecht W.; Ca2+-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci  2000,180(1-2),29-34","journal-title":"J Neurol Sci"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ceca.2013.05.007","volume":"54","author":"Prell T.","year":"2013","unstructured":"Prell T.; Lautenschl&#xE4;ger J.; Grosskreutz J.; Calcium-dependent protein folding in amyotrophic lateral sclerosis. Cell Calcium  2013,54(2),132-143","journal-title":"Cell Calcium"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1096\/fj.12-218875","volume":"27","author":"Hammadi M.","year":"2013","unstructured":"Hammadi M.; Oulidi A.; Gacki&#xE8;re F.; Katsogiannou M.; Slomianny C.; Roudbaraki M.; Dewailly E.; Delcourt P.; Lepage G.; Lotteau S.; Ducreux S.; Prevarskaya N.; Van Coppenolle F.; Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: Involvement of GRP78. FASEB J  2013,27(4),1600-1609","journal-title":"FASEB J"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ceca.2009.12.002","volume":"47","author":"Grosskreutz J.","year":"2010","unstructured":"Grosskreutz J.; Van Den Bosch L.; Keller B.U.; Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium  2010,47(2),165-174","journal-title":"Cell Calcium"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10571-010-9537-5","volume":"30","author":"Mao Q.Q.","year":"2010","unstructured":"Mao Q.Q.; Zhong X.M.; Feng C.R.; Pan A.J.; Li Z.Y.; Huang Z.; Protective effects of paeoniflorin against glutamate-induced neurotoxicity in PC12 cells via antioxidant mechanisms and Ca2+ antagonism. Cell Mol Neurobiol  2010,30(7),1059-1066","journal-title":"Cell Mol Neurobiol"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ptr.3321","volume":"25","author":"Mao Q.Q.","year":"2011","unstructured":"Mao Q.Q.; Zhong X.M.; Li Z.Y.; Huang Z.; Paeoniflorin protects against NMDA-induced neurotoxicity in PC12 cells via Ca2+ antagonism. Phytother Res  2011,25(5),681-685","journal-title":"Phytother Res"},{"key":"ref=224","first-page":"325","volume":"25","author":"You J.","year":"1994","unstructured":"You J.; Tan T.; Kuang A.; Zhong Y.; He S.; Biodistribution and metabolism of 3h-gastrodigenin and 3H-gastrodin in mice. J West China Univ Med Sci  1994,25,325-328","journal-title":"J West China Univ Med Sci"},{"key":"ref=225","first-page":"8","volume":"2","author":"Chen W.D.","year":"2000","unstructured":"Chen W.D.; Lu X.L.; Effect of gastrodin on release of glutamate from cultured nerve cells induced by potassium chloride. Chin J Nat Med  2000,2,8-10","journal-title":"Chin J Nat Med"},{"key":"ref=226","first-page":"1701","volume":"34","author":"Sun R.","year":"2009","unstructured":"Sun R.; Zhang Z.; Huang W.; Lv L.; Yin J.; Protective effects and machanism of muskone on pheochromocytoma cell injure induced by glutamate. Zhongguo Zhongyao Zazhi  2009,34(13),1701-1704","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=227","first-page":"43","volume":"11","author":"Shu-li S.","year":"2004","unstructured":"Shu-li S.; Effects of ligustrazine on L-type calcium current in SH-SY5Y human neuroblastoma. Chinese J Neuroimmunol Neurol  2004,11,43-45","journal-title":"Chinese J Neuroimmunol Neurol"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666231016153606","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/222259\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666231016153606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T17:04:35Z","timestamp":1713373475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/222259\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":227,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x22666231016153606","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}